The role of VCAM-1 in diabetic retinopathy: A systematic review and meta-analysis

J Diabetes Complications. 2023 Jan;37(1):108380. doi: 10.1016/j.jdiacomp.2022.108380. Epub 2022 Dec 5.

Abstract

Objective: Vascular cell adhesion molecule-1 (VCAM-1) plays a regulatory role in inflammatory diseases. However, the exact role of VCAM-1 in diabetic retinopathy (DR) remains unclear, and there is a lack of meta-analyses.

Methods: The role of VCAM-1 in DR was screened by database searching. A random effects model was used, and the estimated mean difference was evaluated.

Results: Twenty articles were included. The level of VCAM-1 increased significantly in the DR group compared with the control group (SMD: 0.67, 95 % CI: 0.34-1.01, P < 0.0001). VCAM-1 levels correlated with sample size and DR type, method and severity based on subgroup analysis.

Conclusion: A high level of VCAM-1 is present in DR patients and is related to the severity of DR. Therefore, VCAM-1 is a potential detection biomarker for DR.

Keywords: Diabetic retinopathy; Meta-analysis; VCAM-1.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Biomarkers
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / diagnosis
  • Humans
  • Vascular Cell Adhesion Molecule-1 / analysis

Substances

  • Vascular Cell Adhesion Molecule-1
  • Biomarkers